$57.72
1.392.47%
Last update: Nov 11, 7:26 PM

MBX Biosciences (MBX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 7, 2026 | $-1.29 | $-0.84 | -53.6 % |
| Q2 | Aug 6, 2026 | $-0.78 | $-0.62 | -25.8 % |
| Q1 | May 7, 2026 | $-0.51 | $-0.59 | 13.6 % |
| Q4 | Mar 12, 2026 | $-0.49 | $-0.61 | 19.7 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.84 | $-0.62 | $-0.59 | $-0.61 |
| Actual | $-1.29 | $-0.78 | $-0.51 | $-0.49 |
| Surprise | -53.6% | -25.8% | +13.6% | +19.7% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.96 | $-0.94 | $-0.77 |
| Revenue | |||
| Consensus | — | — | — |